[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974


DOI: 10.29090/psa.2019.01.016.0012Pharm Sci Asia 2019; 46(1), 12-18

Comparative bioavailaibilty of two valproic acid delayed-release tablets in healthy volunteers with tighter acceptance criteria to anticipate breakthrough seizures

Budi Prasaja*1, Yahdiana Harahap2, Windy Lusthom1, Hardiyanti Hardiyanti1, Theresia Sinandang1, Lia Yumi Yusvita1, Desy Puspita1, Uci Chilmi3, Thomas Anggun3

1 PT. Clinisindo Laboratories, Jakarta, Indonesia
2 Faculty of Pharmacy, University of Indonesia, Depok, Indonesia
3 PT. Novell Pharmaceutical Laboratories, Jakarta, Indonesia

The present study was performed to investigate if the generic of valproic acid delayed release is interchangeable on the basis bioequivalence to the reference product. Due to previous report of breakthrough seizures following a change from a brand name product to a generic product, this bioequivalence study was conducted using tightened acceptance criteria for assuring the therapeutic equivalence. Twenty eight healthy volunteers participated in an open-label, randomized and two-way crossover study under fasting conditions. Plasma samples were collected up 72 hours following drug administration and were determined by liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters used for bioequivalence assessment were AUC0-t, AUC0∞, and Cmax. The 90% CI bioequivalence limits was tightened from the traditional 80.00% -125.00% to 90.00%-111.11%. All volunteers completed the study. The 90% confidence intervals obtained by analysis of variance for AUC0-t, AUC0-∞, and Cmax were 98.38%-104.61%, 98.93%-105.31%, and 92.62%-102.93%, respectively. Both formulations were tolerated and no serious adverse events were reported. These results were all within the range of 90.00-111.11%. The low intra-subject variability observed in this study indicates that tightened acceptance criteria are still applicable for valproic acid BE study.


Bioavailability; Delayedrelease tablet; Pharmacokinetic; Valproic acid

Download full paper (PDF File size: 725.04 KB.)

October - December 2019

See other volume


July - September 2019

See other volume


April - June 2019

See other volume


January - March 2019

See other volume


Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
All Volumes & Issues
Submit Online
Contact us
Faculty of Pharmacy Mahidol University
Mahidol University
Member's menu

You're now loging on with following account:
Guest (unknown)

Please Sign in or Register

Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2024
    Faculty of Pharmacy, Mahidol University, THAILAND

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.